Migraines Headaches News

Treating migraines might reduce stroke risk, researchers suggest

Two early trials show two experimental compounds reduced number of headaches for sufferers

Routine use of imaging tests not recommended, but more docs ordering them anyway, researcher says

Wearable headband uses electrodes to stimulate nerve tied to the headaches

Expectation plays important role in response to treatment, expert says

User presses button to release pulse of magnetic energy that may help ease headache

But it's unknown if allergic conditions bring on headache or vice versa, researcher says

Experts issue new guidelines to avoid unnecessary tests, risky treatments

Study found risk of painful headaches rose with body weight, especially in younger women and whites

MRI findings in study should not cause concern to patients, experts say

Only 416 specialists available nationwide, study found

Study compared patients to see who made the jump to frequent headaches within year

Equal to that for epilepsy, panic disorder, researchers say, with impact of the disability discounted

Study of women identifies important risk factor

Hopelessness, disability may play a role in feelings of despair, study finds

But it's unclear what the finding might mean for patients

Study finds many have side effects so bothersome that sufferers stop taking them

Expert suspects disrupted sleep cycles might play a role in both disorders

MRI study suggests changes occur in areas associated with pain

Small study found no side effects from treatment

Worrying about what may trigger a migraine attack adds to the discomfort of many people with migraines. But according to a new study from Denmark, much of that worry may be unfounded.

The FDA has approved the Zecuity (sumatriptan) skin patch system for treatment of adults who have migraine with or without aura. The single-use, battery-powered patch offers relief of migraine-related nausea as well as migraine headache pain.

Women who get migraines are more likely that those who don't to develop small areas of tissue changes in their brains, a new study shows.

Excedrin Migraine is due back on store shelves by early October, says Milicent Brooks of Novartis, its producer. Other products involved in the recall will roll out after that.

Weather triggers migraine headaches, especially mild ones, a new study shows.